I Chang Selected Research

N,N'-dilinoleylcystamine

1/2004

Pigment-lightening effect of N,N'-dilinoleylcystamine on human melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Chang Research Topics

Disease

5	Insulinoma 05/2005 - 04/2001
3	Neoplasms (Cancer) 04/2001 - 04/2001
2	Melanoma (Melanoma, Malignant) 10/2017 - 01/2004
2	Erythema 08/2009 - 02/2001
2	Type 2 Diabetes Mellitus (MODY) 06/2007 - 05/2003
2	Necrosis 09/2003 - 04/2001
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2002 - 04/2001
2	Alcohol-Related Disorders 10/2001 - 11/2000
2	Pneumococcal Infections 08/2001 - 05/2000
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2001 - 04/2001
1	Hemorrhage 01/2021
1	Multiple Sclerosis 01/2020
1	Type 3 Maturity-Onset Diabetes of the Young 05/2003
1	Acne Vulgaris 03/2003
1	Diabetes Mellitus 03/2002
1	Mental Disorders (Mental Disorder) 10/2001
1	Autoimmune Diseases (Autoimmune Disease) 04/2001
1	Meningococcal Infections 02/2001
1	Meningitis 02/2001
1	Sepsis (Septicemia) 02/2001
1	Pain (Aches) 02/2001
1	Whooping Cough (Pertussis) 05/2000
1	Diphtheria 05/2000
1	Tetanus 05/2000
1	Poliomyelitis (Polio) 05/2000
1	Otitis Media 03/2000

Drug/Important Bio-Agent (IBA)

4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2002 - 04/2001
4	VaccinesIBA 08/2001 - 03/2000
2	Insulin (Novolin)FDA Link 06/2007 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 01/2004 - 05/2000
2	CytokinesIBA 03/2002 - 04/2001
2	Biological ProductsIBA 04/2001 - 04/2001
2	NF-kappa B (NF-kB)IBA 04/2001 - 04/2001
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 02/2001 - 05/2000
2	Conjugate VaccinesIBA 05/2000 - 03/2000
2	CRM197 (non-toxic variant of diphtheria toxin)IBA 05/2000 - 03/2000
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021
1	boldenone undecylenate (Equipoise)IBA 01/2021
1	opicinumabIBA 01/2020
1	Interferon beta-1a FDA Link 01/2020
1	VemurafenibIBA 10/2017
1	Dacarbazine (DIC)FDA LinkGeneric 10/2017
1	SodiumIBA 08/2009
1	VildagliptinIBA 06/2007
1	GABA-A Receptors (GABA(A) Receptor)IBA 05/2005
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2005
1	Cytochromes c (Cytochrome c)IBA 05/2005
1	Mitochondrial Permeability Transition PoreIBA 05/2005
1	CalpainIBA 05/2005
1	calpain inhibitorsIBA 05/2005
1	PK 11195 (PK11195)IBA 05/2005
1	Melanins (Melanin)IBA 01/2004
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2004
1	N,N'-dilinoleylcystamineIBA 01/2004
1	phaeomelaninIBA 01/2004
1	eumelaninIBA 01/2004
1	Oxaloacetic Acid (Oxalacetic Acid)IBA 09/2003
1	alpha-ketoisocaproic acidIBA 09/2003
1	Adenosine Triphosphate (ATP)IBA 09/2003
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 09/2003
1	Streptozocin (Streptozotocin)FDA Link 09/2003
1	Pyruvic Acid (Pyruvate)IBA 09/2003
1	Succinic Acid (Succinate)IBA 09/2003
1	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 05/2003
1	Codon (Codons)IBA 05/2003
1	Arginine (L-Arginine)FDA Link 05/2003
1	Hepatocyte Nuclear FactorsIBA 05/2003
1	Leucine (L-Leucine)FDA Link 05/2003
1	Glucose (Dextrose)FDA LinkGeneric 05/2003
1	Therapeutic UsesIBA 03/2003
1	Niacinamide (Nicotinamide)FDA LinkGeneric 03/2002
1	Pharmaceutical PreparationsIBA 10/2001
1	Caspase InhibitorsIBA 04/2001
1	Interferon-gamma (Interferon, gamma)IBA 04/2001
1	Propidium (Propidium Iodide)IBA 04/2001
1	Bisbenzimidazole (Hoechst 33258)IBA 04/2001
1	InterferonsIBA 04/2001
1	CaspasesIBA 04/2001
1	Interleukin-1 (Interleukin 1)IBA 04/2001
1	PerforinIBA 04/2001
1	Antisense OligonucleotidesIBA 04/2001
1	Fas Ligand Protein (Fas Ligand)IBA 04/2001
1	AmphetaminesIBA 11/2000
1	Blood Alcohol ContentIBA 11/2000
1	Cocaine (Cocaine HCl)IBA 11/2000
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 05/2000
1	AntigensIBA 05/2000

Therapy/Procedure

1	Therapeutics 06/2007
1	Injections 02/2001